Peripherally Inserted Central Catheter (PICC) - Medical Devices Pipeline Assessment, 2017

GlobalData
57 Pages - GLDATA60420
$2,500.00

Summary

GlobalData's Medical Devices sector report, “Peripherally Inserted Central Catheter (PICC) - Medical Devices Pipeline Assessment, 2017" provides an overview of Peripherally Inserted Central Catheter (PICC) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and the number of trials for the key Peripherally Inserted Central Catheter (PICC) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Peripherally Inserted Central Catheter (PICC) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Peripherally Inserted Central Catheter (PICC) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Peripherally Inserted Central Catheter (PICC) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies Mentioned

AngioDynamics Inc
C. R. Bard Inc
University of Texas Health Science Center at Houston

'

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 Peripherally Inserted Central Catheter (PICC) Overview 5
3 Products under Development 6
3.1 Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Stage of Development 6
3.2 Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Territory 7
3.3 Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Regulatory Path 8
3.4 Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Estimated Approval Date 9
4 Peripherally Inserted Central Catheter (PICC) - Pipeline Products under Development by Companies 10
4.1 Peripherally Inserted Central Catheter (PICC) Companies - Pipeline Products by Stage of Development 10
4.2 Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Stage of Development 11
5 Peripherally Inserted Central Catheter (PICC) Companies and Product Overview 12
5.1 AngioDynamics Inc Company Overview 12
5.1.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 12
5.2 C. R. Bard Inc Company Overview 14
5.2.1 C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 14
5.3 University of Texas Health Science Center at Houston Company Overview 17
5.3.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 17
6 Peripherally Inserted Central Catheter (PICC)- Recent Developments 18
6.1 Mar 01, 2017: ICU Medical Announces Fourth Quarter and Fiscal Year 2016 Results 18
6.2 Feb 23, 2017: Teleflex Announces Benson Smith to Retire as Chief Executive Officer at End of 2017; Liam Kelly to Succeed Smith as Chief Executive Officer 18
6.3 Feb 23, 2017: Teleflex Reports Fourth Quarter and Full Year 2016 Results; Provides 2017 Guidance 19
6.4 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 21
6.5 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 23
6.6 Jan 26, 2017: Bard Announces Fourth Quarter Results 24
6.7 Jan 06, 2017: AngioDynamics Reports Fiscal 2017 Second Quarter Results 25
6.8 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 26
6.9 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 29
6.10 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 30
6.11 Nov 14, 2016: AngioDynamics Prices Public Offering of Shares for USD32 Million 30
6.12 Nov 09, 2016: ICU Medical Announces Third Quarter 2016 Results 31
6.13 Nov 09, 2016: AngioDynamics Announces Addition of New Board Members 31
6.14 Oct 27, 2016: Teleflex Reports Third Quarter 2016 Results 32
6.15 Oct 25, 2016: Bard Announces Third Quarter Results 34
6.16 Oct 17, 2016: Teleflex Receives FDA Clearance for the Arrow Midline with Chlorag+ard Technology 35
6.17 Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results 35
6.18 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 36
6.19 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 37
6.20 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 38
6.21 Aug 08, 2016: ICU Medical Announces Second Quarter 2016 Results 40
6.22 Jul 28, 2016: Teleflex Reports Second Quarter 2016 Results 41
6.23 Jul 26, 2016: Bard Announces Second Quarter Results 43
6.24 Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer 43
6.25 Jul 13, 2016: AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results 44
6.26 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 45
6.27 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 46
6.28 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 46
6.29 May 11, 2016: Teleflex Raises USD400 Million in Public Offering of 4.875% Notes Due 2026 49
6.30 May 10, 2016: ICU Medical Announces First Quarter 2016 Results 50
6.31 May 03, 2016: Cook Medical Issues Global, Voluntary Recall of Catheters with Beacon Tip Technology 50
6.32 Apr 21, 2016: Eos Biosciences recruited Thomas Plotts to join the company as its Chief Financial Officer 52
6.33 Apr 07, 2016: AngioDynamics Reports Fiscal 2016 Third Quarter Results 52
7 Appendix 54
7.1 Methodology 54
7.2 About GlobalData 57
7.3 Contact Us 57
7.4 Disclaimer 57

1.1 List of Tables
Table 1: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Stage of Development 6
Table 2: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Territory 7
Table 3: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Regulatory Path 8
Table 4: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Estimated Approval Date 9
Table 5: Peripherally Inserted Central Catheter (PICC) Companies - Pipeline Products by Stage of Development 10
Table 6: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Stage of Development 11
Table 7: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 12
Table 8: BioFlo PICC Line Extension - Product Status 12
Table 9: BioFlo PICC Line Extension - Product Description 12
Table 10: Next Generation BioFlo PICC - Product Status 13
Table 11: Next Generation BioFlo PICC - Product Description 13
Table 12: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 14
Table 13: Anti-Thrombotic PICCs - Product Status 14
Table 14: Anti-Thrombotic PICCs - Product Description 15
Table 15: Antimicrobial PICC - Product Status 15
Table 16: Antimicrobial PICC - Product Description 15
Table 17: COVERT PowerPICC - Product Status 16
Table 18: COVERT PowerPICC - Product Description 16
Table 19: Internal Jugular Placement Catheter - Product Status 16
Table 20: Internal Jugular Placement Catheter - Product Description 16
Table 21: University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 17
Table 22: Automated Catheter Insertion System - Product Status 17
Table 23: Automated Catheter Insertion System - Product Description 17
Table 24: Glossary 56

1.2 List of Figures
Figure 1: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Stage of Development 6
Figure 2: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Territory 7
Figure 3: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Regulatory Path 8
Figure 4: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Estimated Approval Date 9

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838